145020 - Hugel, Inc.

145020 Summary

Biopharma

Stock Price & Overview

₩244,000 +3,500 (+1.46%) Close · Sep 4, 2026 KST

KOSDAQ | ₩KRW | Close: ₩244,000 ≈ US$174 · Market cap ₩3.1tn (≈ $2.2bn)

Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

Symbol	Last Price
298380ABL Bio Inc.	₩71,400 +5.6%
000250Samchundang Pharm	₩157,000 +1.0%
087010Peptron, Inc.	₩157,300 +7.3%
141080LigaChem Biosciences Inc.	₩92,000 +4.2%
302440SK Bioscience Co., Ltd.	₩37,900 +0.4%
009420Hanall Biopharma Co., Ltd.	₩54,700 +1.5%
310210Voronoi, Inc.	₩153,000 +3.9%
214370Caregen Co., Ltd.	₩44,500 +1.5%
347850D & D Pharmatech, Inc.	₩49,200 +1.4%
237690ST Pharm Co., Ltd.	₩101,200 +2.2%

145020 - Hugel, Inc.

145020 DART Filings

Large business group status disclosure — quarterly, individual company

Results of an extraordinary general meeting

Appointment, dismissal or early departure of an independent director

Results of an extraordinary general meeting

Half-Year Report

Supplier Payment Terms and Dispute-Resolution Disclosure

Proxy solicitation reference document

Notice of general meeting of shareholders

Company Statement on a Rumor or Media Report — “undetermined”

Resolution to convene an extraordinary general meeting

Grant of stock options ×5

Material Event — Board Approves Disposal of Treasury Shares

Preliminary Consolidated Results (Fair Disclosure)

Advance notice of results disclosure

Conversion rights exercised

Share pledge that could change the largest shareholder

Share pledge that could change the largest shareholder — released or cancelled

Large business group status disclosure — annual and Q1, individual company

Quarterly Report

Grant of stock options

Record date set, shareholder register closed

Resolution to convene an extraordinary general meeting

Preliminary Consolidated Results (Fair Disclosure)

Company Statement on a Rumor or Media Report — “undetermined”

Insider / Major Shareholder Holdings Report

Insider / Major Shareholder Holdings Report

Investor Relations Event

5% Ownership Report — Large Holdings

Investor Relations Event

5% Ownership Report — Large Holdings ×3

5% Ownership Report — Large Holdings

5% Ownership Report — Short Form

Investor Relations Event

Similar to 145020

What a US investor should know